Legato Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,335
Closed -$681K 638
2024
Q4
$681K Buy
+13,335
New +$655K 0.09% 390
2024
Q3
Sell
-8,235
Closed -$397K 632
2024
Q2
$397K Buy
+8,235
New +$365K 0.05% 470
2024
Q1
Sell
-15,479
Closed -$1M 627
2023
Q4
$1M Sell
15,479
-6,859
-31% -$413K 0.13% 258
2023
Q3
$1.46M Buy
22,338
+5,227
+31% +$329K 0.21% 157
2023
Q2
$995K Buy
+17,111
New +$1.08M 0.13% 261
2023
Q1
Sell
-9,246
Closed -$588K 537
2022
Q4
$588K Buy
+9,246
New +$670K 0.11% 293

Other funds holding NARI

Legato Capital Management's NARI Position: Q1 2025 in Review

Legato Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 13,335 shares — an estimated $681K sold.

Legato Capital Management first reported a position in NARI in Q4 2022 and held it in 6 quarters. The position peaked at $1.46M in Q3 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Legato Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Legato Capital Management sold 13,335 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $681K.
  • Legato Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Legato Capital Management's Inari Medical, Inc. Common Stock position peaked at $1.46M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Legato Capital Management's 13F filing for Q1 2025, filed 6 May 2025.